Stockreport

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

Telix Pharmaceuticals Limited - American Depositary Shares  (TLX) 
PDF MELBOURNE, Australia and INDIANAPOLIS, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has sub [Read more]